EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Deep learning–based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers

Mary P Gronberg, Anuja Jhingran, Tucker J Netherton, Skylar S Gay, Carlos E Cardenas, Christine Chung, David Fuentes, Clifton D Fuller, Rebecca M Howell, Meena Khan, Tze Yee Lim, Barbara Marquez and 7 more

Medical Physics · 2023

DOI: 10.1002/mp.16735 ↗

At a glance

Journal article in Medical Physics, 2023. Written by Mary P Gronberg and 18 co-authors. Institution: Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Major MEDLINE topics: Deep Learning, Radiotherapy, Intensity-Modulated, Neoplasms. Cited 16 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCI NIH HHS, NCATS NIH HHS, Wellcome Trust.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

In recent years, deep‐learning models have been used to predict entire three‐dimensional dose distributions. However, the usability of dose predictions to improve plan quality should be further investigated.

Purpose

To develop a deep‐learning model to predict high‐quality dose distributions for volumetric modulated arc therapy (VMAT) plans for patients with gynecologic cancer and to evaluate their usability in driving plan quality improvements.

Methods

A total of 79 VMAT plans for the female pelvis were used to train (47 plans), validate (16 plans), and test (16 plans) 3D dense dilated U‐Net models to predict 3D dose distributions. The models received the normalized CT scan, dose prescription, and target and normal tissue contours as inputs. Three models were used to predict the dose distributions for plans in the test set. A radiation oncologist specializing in the treatment of gynecologic cancers scored the test set predictions using a 5‐point scale (5, acceptable as‐is; 4, prefer minor edits; 3, minor edits needed; 2, major edits needed; and 1, unacceptable). The clinical plans for which the dose predictions indicated that improvements could be made were reoptimized with constraints extracted from the predictions.

Results

The predicted dose distributions in the test set were of comparable quality to the clinical plans. The mean voxel‐wise dose difference was −0.14 ± 0.46 Gy. The percentage dose differences in the predicted target metrics of and were −1.05% ± 0.59% and 0.21% ± 0.28%, respectively. The dose differences in the predicted organ at risk mean and maximum doses were −0.30 ± 1.66 Gy and −0.42 ± 2.07 Gy, respectively. A radiation oncologist deemed all of the predicted dose distributions clinically acceptable; 12 received a score of 5, and four received a score of 4. Replanning of flagged plans (five plans) showed that the original plans could be further optimized to give dose distributions close to the predicted dose distributions.

Conclusions

Deep‐learning dose prediction can be used to predict high‐quality and clinically acceptable dose distributions for VMAT female pelvis plans, which can then be used to identify plans that can be improved with additional optimization.

Subjects

MeSH terms (MEDLINE)

Deep LearningRadiotherapy, Intensity-ModulatedNeoplasmsHumansFemaleRadiotherapy DosageRadiotherapy Planning, Computer-AssistedOrgans at Risk

Author keywords

artificial intelligencedeep learningdose predictionquality assurance

Authors and institutions

  • Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas, USA.
  • Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Radiation Oncology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Funding

  • NCI NIH HHS
  • NCATS NIH HHS
  • Wellcome Trust
  • Varian Medical Systems

Cite

APA

Gronberg, M. P., Jhingran, A., Netherton, T. J., Gay, S. S., Cardenas, C. E., Chung, C., Fuentes, D., Fuller, C. D., Howell, R. M., Khan, M., Lim, T. Y., Marquez, B., Olanrewaju, A. M., Peterson, C. B., Vazquez, I., Whitaker, T. J., Wooten, Z., Yang, M., & Court, L. E. (2023). Deep learning–based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers. Medical Physics. https://doi.org/10.1002/mp.16735

Vancouver

Gronberg MP, Jhingran A, Netherton TJ, Gay SS, Cardenas CE, Chung C, et al. Deep learning–based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers. Medical Physics. 2023. doi:10.1002/mp.16735

BibTeX
@article{Gronberg2023,
  author = {Gronberg, Mary P and Jhingran, Anuja and Netherton, Tucker J and Gay, Skylar S and Cardenas, Carlos E and Chung, Christine and Fuentes, David and Fuller, Clifton D and Howell, Rebecca M and Khan, Meena and Lim, Tze Yee and Marquez, Barbara and Olanrewaju, Adenike M and Peterson, Christine B and Vazquez, Ivan and Whitaker, Thomas J and Wooten, Zachary and Yang, Ming and Court, Laurence E},
  title = {Deep learning–based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers},
  journal = {Medical Physics},
  year = {2023},
  doi = {10.1002/mp.16735}
}
Start for free →